Craneware (LON:CRW) Stock Price Crosses Below 200-Day Moving Average – What’s Next?

Posted by Joseph Casey on Aug 26th, 2026

Craneware plc (LON:CRW – Get Free Report) shares crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,391.65 and traded as low as GBX 1,272. Craneware shares last traded at GBX 1,296, with a volume of 86,478 shares.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank cut their price objective on Craneware from GBX 2,900 to GBX 2,600 and set a “buy” rating on the stock in a research note on Friday, July 3rd. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat, Craneware presently has an average rating of “Buy” and an average target price of GBX 2,222.75.

Read Our Latest Stock Report on Craneware

Craneware Stock Down 0.6%

The company has a quick ratio of 1.00, a current ratio of 0.76 and a debt-to-equity ratio of 7.93. The stock’s 50-day simple moving average is GBX 1,264.05 and its 200 day simple moving average is GBX 1,389.27. The firm has a market cap of £432.76 million, a P/E ratio of 20.10 and a beta of 0.28.

Insider Transactions at Craneware

In other Craneware news, insider Will Whitehorn bought 640 shares of the business’s stock in a transaction that occurred on Friday, July 3rd. The shares were bought at an average price of GBX 1,173 per share, for a total transaction of £7,507.20. Also, insider Keith Neilson bought 9,074 shares of the firm’s stock in a transaction that occurred on Monday, July 6th. The shares were acquired at an average cost of GBX 1,102 per share, with a total value of £99,995.48. 10.32% of the stock is owned by insiders.

Craneware Company Profile

(Get Free Report)

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.